EXPLORING THE RELATIONSHIP BETWEEN VITAMIN B12 DEFICIENCY AND DIABETIC NEUROPATHY: A CROSS-SECTIONAL STUDY INVESTIGATING POTENTIAL INTERVENTIONS

Main Article Content

Professor Dr Muhammad Rashid Naseem Khan
Dr Muhammad Umair
Dr Waqas Hussain
Inam-u-llah
Maria Rahman
Sharjeel Khawar
Dr. Humera Nazir
Rabiya Naz
Farwa Aslam
Dr Ravi Dutt Sharma

Keywords

Diabetes Mellitus, Diabetic Neuropathy, Vitamin B12 deficiency, Cross-sectional study, Interventions, Health parameters

Abstract

Introduction: Diabetes Mellitus (DM) poses a substantial global health burden, with Diabetic Neuropathy (DN) as a prevalent and debilitating complication. DN is a common and debilitating complication of DM, affecting a substantial proportion of individuals with the condition.  Relationship between diabetes, neuropathy, and micronutrient status, understanding the impact of Vitamin B12 deficiency becomes crucial for optimizing comprehensive care strategies for individuals with diabetes.


Objective: To examine the association between Vitamin B12 deficiency and DN.


Methodology: Adopting a cross-sectional design, the study was conducted from January 2022 to December 2023. The sample size comprised 120 participants diagnosed with Type 2 DM and established DN. In-depth interviews with healthcare professionals explored potential interventions. Quantitative data, including demographics, DM duration, and DN diagnosis through clinical records and nerve conduction studies, were collected. A mixed-methods approach incorporated both quantitative and qualitative data analysis. IBM SPSS v27 facilitated statistical analyses. Continuous variables were expressed as mean ± standard deviation. Differences between groups were tested using independent samples two-tailed t-test. The Spearman correlation coefficient evaluated relationships between continuous variables. Mann–Whitney tests assessed associations with categorical variables. A significance level of p < 0.05 was applied.


Results: The study with 120 participants showed that the active group, with a mean age of 56.8 years (SD 7.9), had a higher age than the total population (mean age 55.2 years, SD 8.3); gender distribution revealed 70.0% males in the active group and 46.7% in the placebo group. Participants experienced a significant increase in Vitamin B12 levels post-treatment (p=0.032). Fasting glucose and HbA1c showed non-significant trends. Lipid profiles varied. Spearman correlation indicated associations between age, glucose, and Vitamin B12. Mann–Whitney tests revealed lower Vitamin B12 ranks in DN-present individuals (p=0.012), while age and time since DM diagnosis showed significant associations.


Conclusion: This study enhances our understanding of the intricate relationship between Vitamin B12 deficiency and DN. The findings underscore the need for targeted interventions to mitigate neuropathic complications associated with Vitamin B12 deficiency, thus optimizing comprehensive care for individuals with DM.

Abstract 299 | pdf Downloads 95

References

1. Sajid M, Mehmood S, Khan MI, Mansha F, Leong-on MS. Frequency of Retinopathy Among Newly Diagnosed Type 2 Diabetes Mellitus Patients. Innovative Research in Applied, Biological and Chemical Sciences. 2023 Jul 1;1(1):50-3.
2. Arokiasamy P, Salvi S, Selvamani Y. Global burden of diabetes mellitus. InHandbook of global health 2021 May 4 (pp. 1-44). Cham: Springer International Publishing. https://link.springer.com/content/pdf/10.1007/978-3-030-05325-3_28-2.pdf
3. Gooch C, Podwall D. The diabetic neuropathies. The neurologist. 2004 Nov 1;10(6):311-22.
4. Bell DS. Metformin‐induced vitamin B12 deficiency can cause or worsen distal symmetrical, autonomic and cardiac neuropathy in the patient with diabetes. Diabetes, Obesity and Metabolism. 2022 Aug;24(8):1423-8.
5. Santos GA, Pardi PC. Biomarkers in Alzheimer’s disease: Evaluation of platelets, hemoglobin and vitamin B12. Dementia & Neuropsychologia. 2020 Mar 16;14:35-40.
6. Sun Y, Sun M, Liu B, Du Y, Rong S, Xu G, Snetselaar LG, Bao W. Inverse association between serum vitamin B12 concentration and obesity among adults in the United States. Frontiers in endocrinology. 2019 Jun 27;10:414.
7. Aroda VR, Edelstein SL, Goldberg RB, Knowler WC, Marcovina SM, Orchard TJ, Bray GA, Schade DS, Temprosa MG, White NH, Crandall JP. Long-term metformin use and vitamin B12 deficiency in the diabetes prevention program outcomes study. The Journal of Clinical Endocrinology & Metabolism. 2016 Apr 1;101(4):1754-61.
8. Reinstatler L, Qi YP, Williamson RS, Garn JV, Oakley Jr GP. Association of biochemical B12 deficiency with metformin therapy and vitamin B12 supplements: the National Health and Nutrition Examination Survey, 1999–2006. Diabetes care. 2012 Feb 1;35(2):327-33.
9. Obeid R, Heil SG, Verhoeven MM, Van den Heuvel EG, De Groot LC, Eussen SJ. Vitamin B12 intake from animal foods, biomarkers, and health aspects. Frontiers in nutrition. 2019 Jun 28;6:93.
10. Aaron S, Kumar S, Vijayan J, Jacob J, Alexander M, Gnanamuthu C. Clinical and laboratory features and response to treatment in patients presenting with vitamin B12 deficiency-related neurological syndromes. Neurology India. 2005 Jan 1;53(1):55.
11. Apte S, Sinha U, Rajput V, Chanchlani R, Chanchlani M. A study of various clinical features manifested due to the deficiency of Vitamin B12 including detailed neurological and haematological features. Journal of evolution of Medical and Dental Sciences. 2013 Nov 25;2(47):9184-90.
12. Pratama S, Lauren BC, Wisnu W. The efficacy of vitamin B12 supplementation for treating vitamin B12 deficiency and peripheral neuropathy in metformin-treated type 2 diabetes mellitus patients: A systematic review. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2022 Oct 1;16(10):102634.
13. Chauhan A, Patil A, Bhosale U, BHAT SD. Screening and Assessment of Polyneuropathy in Diabetic Patients and the Effect of Vitamin B 12 Administration on the Course of Neuropathy. Journal of Clinical & Diagnostic Research. 2018 Aug 1;12(8).
14. Román-Pintos LM, Villegas-Rivera G, Rodríguez-Carrizalez AD, Miranda-Díaz AG, Cardona-Muñoz EG. Diabetic polyneuropathy in type 2 diabetes mellitus: inflammation, oxidative stress, and mitochondrial function. Journal of diabetes research. 2016;2016.
15. Spallone V. Update on the impact, diagnosis and management of cardiovascular autonomic neuropathy in diabetes: what is defined, what is new, and what is unmet. Diabetes & metabolism journal. 2019 Feb 1;43(1):3-0.
16. Nichols QZ. Factors Related to Diabetes Mellitus among Asian-American Adults in the United States Using the 2011 to 2020 National Health and Nutrition Examination Survey (Doctoral dissertation, Virginia Tech).
17. Elsheikh E, Aljohani SS, Alshaikhmubarak MM, Alhawl MA, Alsubaie AW, Alsultan N, Sharif AF, Ali SI, Alshaikhmubarak M. Implications of Iron Deficiency Anaemia on Glycemic Dynamics in Diabetes Mellitus: A Critical Risk Factor in Cardiovascular Disease. Cureus. 2023 Nov 25;15(11).
18. Katulanda P, Ranasinghe P, Jayawardena R, Constantine GR, Sheriff MR, Matthews DR. The prevalence, patterns and predictors of diabetic peripheral neuropathy in a developing country. Diabetology & metabolic syndrome. 2012 Dec;4:1-8.
19. American Diabetes Association. Standards of medical care in diabetes—2019 abridged for primary care providers. Clinical diabetes: a publication of the American Diabetes Association. 2019 Jan;37(1):11.
20. Didangelos T, Karlafti E, Kotzakioulafi E, Margariti E, Giannoulaki P, Batanis G, Tesfaye S, Kantartzis K. Vitamin B12 supplementation in diabetic neuropathy: a 1-year, randomized, double-blind, placebo-controlled trial. Nutrients. 2021 Jan 27;13(2):395.
21. Tesfaye S, Selvarajah D. Advances in the epidemiology, pathogenesis and management of diabetic peripheral neuropathy. Diabetes/metabolism research and reviews. 2012 Feb;28:8-14.
22. Grundy SM, Hansen B, Smith Jr SC, Cleeman JI, Kahn RA, Conference Participants. Clinical management of metabolic syndrome: report of the American Heart Association/National Heart, Lung, and Blood Institute/American Diabetes Association conference on scientific issues related to management. Circulation. 2004 Feb 3;109(4):551-6.
23. Carmel R. Biomarkers of cobalamin (vitamin B-12) status in the epidemiologic setting: a critical overview of context, applications, and performance characteristics of cobalamin, methylmalonic acid, and holotranscobalamin II. The American journal of clinical nutrition. 2011 Jul 1;94(1):348S-58S.
24. Mazidi M, Webb RJ, George ES, Shekoohi N, Lovegrove JA, Davies IG. Nutrient patterns are associated with discordant apoB and LDL: a population-based analysis. British Journal of Nutrition. 2022 Aug;128(4):712-20.
25. Neal ES, Kumar V, Borges K, Cuffe JS. Vitamin B12 deficiency induces glucose intolerance, delays peak insulin levels and promotes ketogenesis in female rats. Journal of Endocrinology. 2023 Feb 1;256(2).
26. Kharroubi AT, Darwish HM. Diabetes mellitus: The epidemic of the century. World journal of diabetes. 2015 Jun 6;6(6):850.
27. Al-Salameh A, Chanson P, Bucher S, Ringa V, Becquemont L. Cardiovascular disease in type 2 diabetes: a review of sex-related differences in predisposition and prevention. InMayo Clinic Proceedings 2019 Feb 1 (Vol. 94, No. 2, pp. 287-308). Elsevier.